Physician
Hematology
Dr. David Taber, MD
|
|
Give Review
David Taber is an expert in the field of Hematology. He attended University of Illinois College of Medicine. David Taber is a published physician. He has 7 papers published. The most current publication "Erlotinib and Bevacizumab in Newly Diagnosed Performance Status 2 or Elderly Patients With Nonsquamous Non-Small-Cell Lung Cancer, a Phase II Study of the Hoosier Onco..." He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Erlotinib and Bevacizumab in Newly Diagnosed Performance Status 2 or Elderly Patients With Nonsquamous Non-Small-Cell Lung Cancer, a Phase II Study of the Hoosier Onco...
- The epothilone B analogue ixabepilone in patients with advanced hepatobiliary cancers: a trial of the University of Chicago Phase II Consortium.
- Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer.
- A phase II trial of UFT and leucovorin in women 65 years and older with advanced breast cancer.
- Phase II trial of PS-341 in patients with renal cell cancer: a University of Chicago phase II consortium study.
- Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil in patients with metastatic renal cell cancer.
Schools
Indiana University School Of Medicine
University Of Al Hospital
Doctors Specialties
- Diagnostic Radiology
- Hematology
Accepted Insurances
Education
-
John H. Stroger Hospital of Cook County -
University of Illinois College of Medicine
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1740377845 |
| Last Name Of The Provider | TABER |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
|
Dr. James M. Stafford, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael McGinley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thuy L. Vu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Valerie M. Jansen, MD |
|
|
Dr. Rajoo Dhangana, MD |